TickerFacts.

Oncotelic Therapeutics, Inc. (OTLC): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$70.0K
Year ended 2023-12-31
-65.7%
3-year compound annual growth
$1.74M2020-12-31: $1.74M2023-12-31: $70.0K$70.0K
2020-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$70.0Kn/a2025-04-15, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31$1.74Mn/a2022-04-15, From 2020-01-01